Effects of β3-Adrenergic Receptor Antagonism in Septic Shock
Author Information
Author(s): Hagimont Eugénie, Lourenco-Rodrigues Marc-Damien, Chousterman Benjamin-Glenn, Yen-Potin Frances, Durand Manon, Kimmoun Antoine
Primary Institution: Université de Lorraine
Hypothesis
Does β3-adrenergic receptor antagonism improve cardiac and vascular functions in septic shock without affecting survival?
Conclusion
Inhibition of β3-adrenergic receptors improves cardiac and vascular function in septic shock but does not enhance survival.
Supporting Evidence
- β3-AR density increased on endothelial cells during septic shock.
- Antagonist treatment improved mean arterial pressure and cardiac index.
- Survival rates remained unchanged despite improved hemodynamic parameters.
Takeaway
Blocking a specific receptor in the heart helps the heart and blood vessels work better during a serious infection, but it doesn't help the mice live longer.
Methodology
Wild-type mice underwent cecal ligation and puncture to induce septic shock, followed by treatment with β3-AR agonist or antagonist and measurement of hemodynamic parameters.
Potential Biases
Potential differences in responses between male and female mice could introduce bias.
Limitations
The study's model may not fully replicate human septic shock, and the sample size may limit the statistical power.
Participant Demographics
Wild-type mice, both male and female, aged 12-16 weeks.
Statistical Information
P-Value
p=0.007 for MAP improvement with antagonist treatment.
Confidence Interval
95% CI [−39.5; −22.2] for MAP changes.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website